LTRN
Price
$3.57
Change
+$0.17 (+5.00%)
Updated
Jun 4, 01:14 PM (EDT)
Capitalization
43.38M
69 days until earnings call
Intraday BUY SELL Signals
RCKT
Price
$2.91
Change
-$0.01 (-0.34%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
315.57M
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LTRN vs RCKT

Header iconLTRN vs RCKT Comparison
Open Charts LTRN vs RCKTBanner chart's image
LTRN vs RCKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LTRN vs. RCKT commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and RCKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (LTRN: $3.40 vs. RCKT: $2.92)
Brand notoriety: LTRN and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 26% vs. RCKT: 110%
Market capitalization -- LTRN: $43.38M vs. RCKT: $315.57M
LTRN [@Biotechnology] is valued at $43.38M. RCKT’s [@Biotechnology] market capitalization is $315.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both LTRN and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 6 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • LTRN’s TA Score: 6 bullish, 4 bearish.
  • RCKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than RCKT.

Price Growth

LTRN (@Biotechnology) experienced а +2.72% price change this week, while RCKT (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.33%. For the same industry, the average monthly price growth was +0.56%, and the average quarterly price growth was +6.32%.

Reported Earning Dates

LTRN is expected to report earnings on Aug 12, 2026.

RCKT is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (-0.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($316M) has a higher market cap than LTRN($43.4M). LTRN YTD gains are higher at: 12.211 vs. RCKT (-16.809). LTRN has higher annual earnings (EBITDA): -19.65M vs. RCKT (-197.31M). RCKT has more cash in the bank: 144M vs. LTRN (12.4M). LTRN has less debt than RCKT: LTRN (94K) vs RCKT (24.8M). LTRN (0) and RCKT (0) have equivalent revenues.
LTRNRCKTLTRN / RCKT
Capitalization43.4M316M14%
EBITDA-19.65M-197.31M10%
Gain YTD12.211-16.809-73%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.4M144M9%
Total Debt94K24.8M0%
FUNDAMENTALS RATINGS
LTRN vs RCKT: Fundamental Ratings
LTRN
RCKT
OUTLOOK RATING
1..100
3758
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3765
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (15) in the Biotechnology industry is somewhat better than the same rating for LTRN (57) in the null industry. This means that RCKT’s stock grew somewhat faster than LTRN’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LTRN (100) in the null industry. This means that RCKT’s stock grew similarly to LTRN’s over the last 12 months.

RCKT's SMR Rating (99) in the Biotechnology industry is in the same range as LTRN (99) in the null industry. This means that RCKT’s stock grew similarly to LTRN’s over the last 12 months.

LTRN's Price Growth Rating (37) in the null industry is in the same range as RCKT (65) in the Biotechnology industry. This means that LTRN’s stock grew similarly to RCKT’s over the last 12 months.

LTRN's P/E Growth Rating (100) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that LTRN’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LTRNRCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LTRN
Daily Signal:
Gain/Loss:
RCKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UAPIX101.36N/A
N/A
ProFunds UltraSmall Cap Inv
KTCSX59.87N/A
N/A
DWS Science and Technology S
BTMKX21.25N/A
N/A
iShares MSCI EAFE Intl Idx K
DWUSX22.05N/A
N/A
DFA World ex US Targeted Val Instl
SNTFX22.73N/A
N/A
Steward Values Enhanced International R6

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ALZN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-9.09%
ALZN - LTRN
39%
Loosely correlated
+0.88%
PDSB - LTRN
38%
Loosely correlated
-6.90%
GLMD - LTRN
36%
Loosely correlated
-1.61%
RCKT - LTRN
36%
Loosely correlated
+1.04%
AXON - LTRN
36%
Loosely correlated
-1.76%
More